Regeneron combines proprietary antibody and genetics platforms to discover medicines in immunology, oncology, and ophthalmology. Its Regeneron Genetics Center has sequenced millions of exomes, fueling target discovery across its pipeline.
R&D SPEND
$4.4B
INDUSTRY
Biopharma
310
ACADEMIC COLLABORATIONS
3500
PATENTS
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED